Crescent Capital BDC (CCAP) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Net investment income for Q2 2024 was $21.7 million ($0.59 per share), up from $20.6 million ($0.56 per share) in Q2 2023, driven by higher interest income from rising benchmark rates.
Net asset value per share rose to $20.30 at June 30, 2024, the highest since June 2022, up from $20.04 at year-end.
Portfolio fair value reached $1.61 billion, diversified across 183 companies in 20 industries, with 90% in first lien or unitranche first lien investments.
Regular dividend of $0.42 per share and a supplemental dividend of $0.09 per share declared for Q2 2024; Q3 2024 regular dividend also declared.
Portfolio remains defensively positioned with strong credit performance and stable NAV profile.
Financial highlights
Total investment income for Q2 2024 was $49 million, down from $50.4 million in the prior quarter but up year-over-year; net investment income per share decreased sequentially from $0.63 to $0.59.
GAAP/net income per share for Q2 2024 was $0.55, reflecting net investment income outpacing dividends, offset by net losses.
Net realized and unrealized losses on investments per share totaled ($0.04) in Q2 2024.
Stockholders' equity/net assets rose modestly to $752 million.
Total assets increased to $1.67 billion; debt-to-equity ratio at 1.18x.
Outlook and guidance
Confident in continued strong portfolio performance and ability to deliver attractive risk-adjusted returns for the remainder of 2024.
Plan to continue regular and supplemental dividends, with strong coverage and asset coverage ratio at 184%.
Management continues to focus on disciplined portfolio construction and conservative investment strategy.
Latest events from Crescent Capital BDC
- Q4 2024 featured stable NAV, strong liquidity, robust dividends, and a diversified portfolio.CCAP
Q4 20249 Jul 2026 - Directors were elected for three-year terms and the auditor was ratified with no shareholder questions.CCAP
AGM 202621 May 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 202614 May 2026 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 20256 May 2026 - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025